Company to Present Solutions Alongside Hewlett-Packard in Hall 16, Booth D21-6
VANCOUVER, British Columbia, November 09, 2022 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce it will be exhibiting at the world’s largest event for the medical sector in Düsseldorf, Germany from November 14 to 17, 2022.
The Medica event is the largest medical trade fair in the world. Annually, it attracts thousands of exhibitors from more than 50 countries. Leading individuals from the fields of business, research, and politics attend this industry leading event — alongside tens of thousands of national and international experts and decision-makers from the sector. An extensive exhibition and an ambitious program — which together present the entire spectrum of innovations for outpatient and clinical care.
UniDoc has joined Hewlett-Packard in Hall 16, Booth D21-6 and will be presenting product information and providing one-on-one meeting opportunities in during the event. The UniDoc Virtual Care Solutions Model (“VCSM”), is a proprietary, customizable, and comprehensive telehealth solution based on a variety of integrated physical enclosures, kiosks, and related configurable packaging designed to deliver web-based services and analytical tools in combination with access to a developing network of healthcare providers, pharmacies, and hospitals.
Interested attendees who wish to pre-book an in-person meeting with a Company representative are invited to email firstname.lastname@example.org indicating available times and dates along with reply contact information. All attempts will be made to accommodate your interest subject to availability.
UniDoc CEO Tony Baldassarre says, “I’m very excited meet with the medical community in person at Medica this year. The timing is perfect for us to reach the people in our target audience and demonstrate how our unique offering fits with their individual care models. I’m keen to broaden our network and to continue learning how we can support the needs of this growing market.”
On Behalf of the Board of Directors,
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.
For further information, please contact
UniDoc Investor Relations
Tel: +1 778.383.6731
Matt Chatterton, Director
Tel: +1 778.613.2082
Media Inquiries email@example.com
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company’s participation in the Medica event.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to successfully develop and commercialize VCSM kiosks; risks that current and any future global supply chain issues will delay the development of the VCSM kiosks; risks that the Company will not be able to secure required financing on reasonable terms or at all; geopolitical risks and other business risks associated with and specific to foreign jurisdictions in which the Company may do business; risks with respect to the implementation of laws and regulations that may impose restrictions on the Company’s product offering in the jurisdictions in which the Company may do business; as well as all of the other risks as described in the Company’s final prospectus dated December 2, 2021 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.